Clinical Trial Update: A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast Cancer [Phase 3]

View source ↗

Summary

Takeda announced results from a Phase 3 trial evaluating TAP-144-SR(6M) in postoperative and hormone therapy-naïve premenopausal breast cancer patients. Results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TAP-144-SR(6M)

Snippet

Sponsor: Takeda | Conditions: Premenopausal Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-11-26